Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Incyte Corporation (INCY)

« Back to company index

INCY Chatter Timeline

Stock Ticker for INCY

Most Active Tweeters for INCY

UserTweets
@mediasentiment 14
@InsiderAlerts4U 11
@FlashAlert_me 10
@Tickeron 8
@newsfilterio 7

Recent Tweets for INCY

dhovekamp42 @dhovekamp42
RT @bradloncar: $INCY is withdrawing the New Drug Application (NDA) for parsaclisib for the treatment of patients with relapsed or refracto…
12:01am
StckPro @StckPro
$INCY NEW ARTICLE : Mizuho Securities Sticks to Its Hold Rating for Incyte (INCY) https://t.co/N9O2Ke7doR Get all t… https://t.co/U3HKcyuWLl
12:01am
SVENNIECO @SVENNIECO
Incyte drops US filing for parsaclisib in non-Hodgkin lymphomas $INCY $MRUS https://t.co/hPYygpmtTK
January 25th 2022, 11:01pm
SVENNIECO @SVENNIECO
Incyte drops US filing for parsaclisib in non-Hodgkin lymphomas $INCY $MRUS https://t.co/o2FiLc1cNY
January 25th 2022, 11:01pm
Briefingcom @Briefingcom
$INCY: Incyte withdraws NDA for parsaclisib; confirms opt-out of development of MCLA-145 https://t.co/yCWwk0Q0pr
January 25th 2022, 11:01pm
fwpharma @fwpharma
Incyte drops US filing for parsaclisib in non-Hodgkin lymphomas $INCY $MRUS https://t.co/xdgK8DrX1q
January 25th 2022, 11:01pm
newsfilterio @newsfilterio
Incyte Provides Update on Parsaclisib and MCLA-145 $INCY https://t.co/fM6LNxIbDo
January 25th 2022, 11:01pm
MarcJacksonLA @MarcJacksonLA
$INCY $MRUS Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/BIozmsZA5s
January 25th 2022, 11:01pm
newsfilterio @newsfilterio
Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145 $INCY $MRUS https://t.co/R3BCO4qqzi
January 25th 2022, 10:01pm
StckPro @StckPro
$INCY NEW ARTICLE : Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/XfM0TBijCO Get all the latest… https://t.co/VZ4Cm6fsiF
January 25th 2022, 9:01pm
Sanctuary_Bio @Sanctuary_Bio
not gonna lie, I was surprised when $INCY was an ASH winner, I didn't think the data was that competitive oh well,… https://t.co/MK46izoFpj
January 25th 2022, 9:01pm
newsinthemarket @newsinthemarket
Incyte withdraws NDA for parsaclisib, opts out from further MCLA-145 development $INCY
January 25th 2022, 9:01pm
phasefivebot @phasefivebot
$INCY Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/WFC101f16F
January 25th 2022, 9:01pm
MarketNFlash @MarketNFlash
Merus Appoints Shannon Campbell As Chief Commercial Officer And Regains Worldwide Rights To MCLA-145 | $INCY $MRUS
January 25th 2022, 9:01pm
bradloncar @bradloncar
$INCY is withdrawing the New Drug Application (NDA) for parsaclisib for the treatment of patients with relapsed or… https://t.co/yuRyAAvoFX
January 25th 2022, 9:01pm
FlashAlert_me @FlashAlert_me
$INCY [15s. delayed]: Issued Press Release on January 25, 16:30:00: Incyte Provides Update on Parsaclisib and MCLA-… https://t.co/QUkU0G7yJV
January 25th 2022, 9:01pm
ZoZoStockwatch @ZoZoStockwatch
RT @TheTradeXchange: $INCY: Incyte Provides Update on Parsaclisib and MCLA-145
January 25th 2022, 9:01pm
StockNewsBot2 @StockNewsBot2
$INCY Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/Rn30Qw9pYI
January 25th 2022, 9:01pm
TheTradeXchange @TheTradeXchange
$INCY: Incyte Provides Update on Parsaclisib and MCLA-145
January 25th 2022, 9:01pm
stock_titan @stock_titan
$INCY Incyte Provides Update on Parsaclisib and MCLA-145 https://t.co/F9mtMMtKV8
January 25th 2022, 9:01pm
perrone_ken @perrone_ken
RT @bio_clouseau: Regarding $SRRA Momelotinib vs $INCY Rux, simplify-1 gives an answer albeit in jak naive MF patients https://t.co/mKF6asX…
January 25th 2022, 2:01pm
BayAreaBiotechI @BayAreaBiotechI
$SRRA back to Dec. 2021 highs on positive ph3 #MF data today. I guess in this market that is a win? $INCY #ruxwatchout
January 25th 2022, 2:01pm
bio_clouseau @bio_clouseau
Regarding $SRRA Momelotinib vs $INCY Rux, simplify-1 gives an answer albeit in jak naive MF patients https://t.co/mKF6asXzDl
January 25th 2022, 12:01pm
DoraWri58503474 @DoraWri58503474
$INCY *Hey guys, I've made $55K with them in a week, by their alerts ,._, https://t.co/2VrS0WNsPk
January 25th 2022, 3:01am
Thestory0fmoney @Thestory0fmoney
$INCY https://t.co/aRINTKCFXU
January 25th 2022, 1:01am
mediasentiment @mediasentiment
$INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 843
January 24th 2022, 9:01pm
ChartMill @ChartMill
Our 'Technical Setups in Strongly Growing Stocks' lists $INCY today! https://t.co/vmjZdBXHkD
January 24th 2022, 9:01pm
ChartMill @ChartMill
Our 'Technical Setups in Strongly Growing Stocks' lists $INCY today! https://t.co/BHiDVVTVaM
January 24th 2022, 5:01pm
Ba4Saso @Ba4Saso
$INCY Waiting for Short signal. Chart by https://t.co/z6vAd7dl0q https://t.co/GrLRFMZXbG
January 24th 2022, 5:01pm
LancerLancer_ @LancerLancer_
@TaPlot @11dbrowns $INCY
January 24th 2022, 3:01pm
ShortAlgoKing @ShortAlgoKing
$INCY Awaiting Short Signal. Chart by https://t.co/qchl9O5K2n https://t.co/YPzT6wgmQw
January 24th 2022, 11:01am
mediasentiment @mediasentiment
$INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 369
January 24th 2022, 11:01am
InvestorSimply @InvestorSimply
$INCY - Incyte: Still Has Room To Grow. https://t.co/KKmBKPgDSV #investing #finance #stockmarket
January 24th 2022, 8:01am
newsfilterio @newsfilterio
Incyte: Still Has Room To Grow $INCY https://t.co/d1AycCjNYZ
January 24th 2022, 5:01am
StckPro @StckPro
$INCY NEW ARTICLE : Incyte: Still Has Room To Grow https://t.co/iC83vwBbhR Get all the latest $INCY related news he… https://t.co/mkVs2Vqpra
January 24th 2022, 5:01am
SeekingAlpha @SeekingAlpha
$INCY - Incyte: Still Has Room To Grow. https://t.co/ULsAJ34NiA #investing #finance #stockmarket
January 24th 2022, 5:01am
dafster17 @dafster17
$INCY https://t.co/fMVadu0W0d
January 24th 2022, 4:01am
optioncharts @optioncharts
$INCY Implied Volatility expiration 02/18/2022 #maxpain #options https://t.co/Smo479v48n https://t.co/OgqCsBfSVf
January 24th 2022, 2:01am
mediasentiment @mediasentiment
$INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 13
January 24th 2022, 1:01am
MarcJacksonLA @MarcJacksonLA
$INCY Incyte Expected to Post Quarterly Sales of $826.27 Million | https://t.co/NKb5pRLCDo https://t.co/HUND12UmND
January 23rd 2022, 3:01pm
Tickeron @Tickeron
$INCY enters an Uptrend because Momentum Indicator exceeded the 0 level on January 14, 2022. View odds for this and… https://t.co/fLqATW42DY
January 23rd 2022, 11:01am
mediasentiment @mediasentiment
$INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 306
January 23rd 2022, 11:01am
mediasentiment @mediasentiment
$INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 305
January 23rd 2022, 11:01am
SamuelK32972932 @SamuelK32972932
$INCY ~Find active market alerts here in this best trading community.https://t.co/kmu9qtltyP
January 23rd 2022, 2:01am
FinancialAdvBot @FinancialAdvBot
Buy the dip $INCY! https://t.co/7VLTGRYRlV
January 23rd 2022, 2:01am
Tickeron @Tickeron
$INCY enters an Uptrend as Momentum Indicator exceeded the 0 level on January 14, 2022. View odds for this and othe… https://t.co/olUPtoUZ5P
January 22nd 2022, 11:01pm
optioncharts @optioncharts
$INCY Implied Volatility expiration 02/18/2022 #maxpain #options https://t.co/Smo479v48n https://t.co/dwpCee8QAM
January 22nd 2022, 7:01pm
mediasentiment @mediasentiment
$INCY new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 205
January 22nd 2022, 10:01am
InsiderAlerts4U @InsiderAlerts4U
$INCY: New Insider Filing on INCYTE CORP's EVP & General Counsel MARIA E PASQUALE: https://t.co/rkCyAiVS2l
January 22nd 2022, 8:01am
Jhswings27 @Jhswings27
$INCY volume breaking out the further this goes down the channel. Move to $82 volume shelf coming. https://t.co/IE6ROm5xTy
January 22nd 2022, 7:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.